Jun 21, 2023 5:40pm EDT

Medexus Generates Record Revenue of Us$108.1 Million in Fiscal Year 2023

Jun 15, 2023 7:25am EDT

FDA Accepts for Review Medexus's IXINITY Supplemental Biological License Application for Pediatric Patients

Jun 14, 2023 5:30pm EDT

Medexus Schedules Fourth Fiscal Quarter and Fiscal Year 2023 Conference Call

Jun 13, 2023 7:25am EDT

Medexus Highlights Data on Trecondyv (Treosulfan) Presented at MDS 2023

Jun 01, 2023 5:30pm EDT

Medexus to Participate in the LD Micro Invitational XIII

May 10, 2023 5:30pm EDT

Medexus Announces Normal Course Issuer Bid, or NCIB, for Its Convertible Debentures

May 09, 2023 6:21pm EDT

Medexus Demonstrates Cost-Effectiveness of Gleolan-Guided Surgery for High-Grade Glioma

Apr 18, 2023 5:30pm EDT

Medexus to Participate in the 2023 Bloom Burton & Co. Healthcare Investor Conference

Apr 11, 2023 7:25am EDT

Medexus Expects Record Revenue for Fiscal Year 2023 and Provides Business Update

Mar 22, 2023 7:20am EDT

Medexus Announces New License Deal for Topical Terbinafine